Gilead Sciences Inc (GILD)

TradeGate
Currency in EUR
98.10
+0.63(+0.65%)
Delayed Data
Fair Value
Day's Range
97.0699.31
52 wk Range
57.18112.18
Gilead Sciences Inc is not on our AI-picked strategiesExplore current and previous stocks selected by AI
Key Statistics
Edit
Bid/Ask
98.02 / 98.14
Prev. Close
97.47
Open
98.13
Day's Range
97.06-99.31
52 wk Range
57.18-112.18
Volume
7.53K
Average Volume (3m)
5.24K
1-Year Change
44.44%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GILD Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
No news in this category
Looks like there are no results in this news category

Gilead Sciences Inc Company Profile

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for virology, oncology and other therapeutic areas in the United States, Europe, and internationally. The company offers Biktarvy, Genvoya, Descovy, Odefsey, Complera/Eviplera, Symtuza, Truvada, Stribild, and Sunlenca products for the treatment of HIV-1 infection; Veklury, an injection for intravenous use for the treatment of COVID-19; and Epclusa, Vemlidy, Harvoni, Viread, and Livdelzi for the treatment of liver disease. It also provides Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. In addition, the company’s portfolio of market products includes Atripla, Cayston, Descovy for PrEP, Emtriva, Hepcludex, Hepsera, Jyseleca, Sovaldi, Truvada for PrEP, Tybost, Vosevi, and Zydelig. It has collaboration agreements with Arcellx, Inc.; Merck & Co., Inc.; Arcus Biosciences, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Everest Medicines; Abingworth LLP; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Compare GILD to Peers and Sector

Metrics to compare
GILD
Peers
Sector
Relationship
P/E Ratio
0.0x−1.7x−0.5x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x0.9x2.6x
Price / LTM Sales
0.0x4.6x3.0x
Upside (Analyst Target)
0.0%299.7%53.8%
Fair Value Upside
Unlock21.4%9.6%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Gilead (GILD) Stock Price Today?

The Gilead stock price today is 98.10.

What Stock Exchange Does Gilead Trade On?

Gilead is listed and trades on the TradeGate stock exchange.

What Is the Stock Symbol for Gilead?

The stock symbol for Gilead is "GILD."

What Is the Gilead Market Cap?

As of today, Gilead market cap is 122.15B.

From a Technical Analysis Perspective, Is GILD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.